George Gauthier
Corporate Officer/Principal chez IGM BIOSCIENCES, INC.
Fortune : 303 261 $ au 30/04/2024
Profil
George A.
Gauthier is currently the Chief Commercial Officer at IGM Biosciences, Inc. Previously, he worked as the Vice President-Global Product Strategy at Genentech, Inc. He received his undergraduate degree from Michigan State University and his MBA from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IGM BIOSCIENCES, INC.
0,12% | 29/11/2023 | 39 642 ( 0,12% ) | 303 261 $ | 30/04/2024 |
Postes actifs de George Gauthier
| Sociétés | Poste | Début |
|---|---|---|
| IGM BIOSCIENCES, INC. | Corporate Officer/Principal | 12/04/2021 |
Anciens postes connus de George Gauthier
| Sociétés | Poste | Fin |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/04/2021 |
Formation de George Gauthier
| Michigan State University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IGM BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |